This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Walser, T. C. Articles by Fulton, A. M. Search for Related Content PubMed PubMed Citation Articles by Walser, T. C. Articles by Fulton, A. M.

Antagonism of CXCR3 Inhibits Lung Metastasis in a Murine Model of Metastatic Breast Cancer

¹ Department of Pathology, University of Maryland School of Medicine, ² University of Maryland School of Nursing, and ³ University of Maryland Greenebaum Cancer Center, Baltimore, Maryland; and ⁴ Amgen, South San Francisco, California

Requests for reprints: Amy M. Fulton, Department of Pathology, University of Maryland School of Medicine, 10 South Pine Street, Baltimore, MD 21201. Phone: 410-706-6479; Fax: 410-706-8414; E-mail: afulton{at}umaryland.edu.

Tumor cells aberrantly express chemokines and/or chemokine receptors, and some may promote tumor growth and metastasis. We examined the expression and function of chemokine receptor CXCR3 in a syngeneic murine model of metastatic breast cancer. By flow cytometry, CXCR3 was detected in all murine mammary tumor cell lines examined. All human breast cancer cell lines examined also expressed CXCR3, as did the immortalized but nontumorigenic MCF-10A cell line. Interaction of CXCR3 ligands, CXCL9, CXCL10, and CXCL11, with CXCR3 on the highly malignant murine mammary tumor cell line 66.1 resulted in intracellular calcium mobilization and chemotaxis in vitro. To test the hypothesis that tumor metastasis is facilitated by CXCR3 expressed by tumor cells, we employed a small molecular weight antagonist of CXCR3, AMG487. 66.1 tumor cells were pretreated with AMG487 prior to i.v. injection into immune-competent female mice. Antagonism of CXCR3 on 66.1 tumor cells inhibited experimental lung metastasis, and this antimetastatic activity was compromised in mice depleted of natural killer cells. Systemic administration of AMG487 also inhibited experimental lung metastasis. In contrast to the antimetastatic effect of AMG487, local growth of 66.1 mammary tumors was not affected by receptor antagonism. These studies indicate that murine mammary tumor cells express CXCR3 which facilitates the development of lung metastases. These studies also indicate for the first time that a small molecular weight antagonist of CXCR3 has the potential to inhibit tumor metastasis. (Cancer Res 2006; 66(15): 7701-7)

This article has been cited by other articles:

				V. L. Martins, J. J. Vyas, M. Chen, K. Purdie, C. A. Mein, A. P. South, A. Storey, J. A. McGrath, and E. A. O'Toole Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen J. Cell Sci., June 1, 2009; 122(11): 1788 - 1799. [Abstract] [Full Text] [PDF]

				X. Ma, K. Norsworthy, N. Kundu, W. H. Rodgers, P. A. Gimotty, O. Goloubeva, M. Lipsky, Y. Li, D. Holt, and A. Fulton CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model Mol. Cancer Ther., March 1, 2009; 8(3): 490 - 498. [Abstract] [Full Text] [PDF]

				D. Datta, A. G. Contreras, M. Grimm, A. M. Waaga-Gasser, D. M. Briscoe, and S. Pal Calcineurin Inhibitors Modulate CXCR3 Splice Variant Expression and Mediate Renal Cancer Progression J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2437 - 2446. [Abstract] [Full Text] [PDF]

				C. M. Cameron, M. J. Cameron, J. F. Bermejo-Martin, L. Ran, L. Xu, P. V. Turner, R. Ran, A. Danesh, Y. Fang, P.-K. M. Chan, et al. Gene Expression Analysis of Host Innate Immune Responses during Lethal H5N1 Infection in Ferrets J. Virol., November 15, 2008; 82(22): 11308 - 11317. [Abstract] [Full Text] [PDF]

				J. A. Abrams, P. C. Lee, J. L. Port, N. K. Altorki, and A. I. Neugut Cigarette Smoking and Risk of Lung Metastasis from Esophageal Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2707 - 2713. [Abstract] [Full Text] [PDF]

				D. Verzijl, S. Storelli, D. J. Scholten, L. Bosch, T. A. Reinhart, D. N. Streblow, C. P. Tensen, C. P. Fitzsimons, G. J. R. Zaman, J. E. Pease, et al. Noncompetitive Antagonism and Inverse Agonism as Mechanism of Action of Nonpeptidergic Antagonists at Primate and Rodent CXCR3 Chemokine Receptors J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 544 - 555. [Abstract] [Full Text] [PDF]

				D. Baatar, P. Olkhanud, D. Newton, K. Sumitomo, and A. Biragyn CCR4-Expressing T Cell Tumors Can Be Specifically Controlled via Delivery of Toxins to Chemokine Receptors J. Immunol., August 1, 2007; 179(3): 1996 - 2004. [Abstract] [Full Text] [PDF]

				A. Zipin-Roitman, T. Meshel, O. Sagi-Assif, B. Shalmon, C. Avivi, R. M. Pfeffer, I. P. Witz, and A. Ben-Baruch CXCL10 Promotes Invasion-Related Properties in Human Colorectal Carcinoma Cells Cancer Res., April 1, 2007; 67(7): 3396 - 3405. [Abstract] [Full Text] [PDF]